116 related articles for article (PubMed ID: 36552885)
1. Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data.
Poisson LM; Sreekumar A; Chinnaiyan AM; Ghosh D
Genomics; 2012 May; 99(5):265-74. PubMed ID: 22497771
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of gene expression data including an assessment of pathway enrichment for predicting prostate cancer.
Hu P; Greenwood CM; Beyene J
Cancer Inform; 2007 Feb; 2():289-300. PubMed ID: 19458772
[TBL] [Abstract][Full Text] [Related]
3. Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone.
de Anda-Jáuregui G; Guo K; McGregor BA; Feldman EL; Hur J
BMC Syst Biol; 2019 Jan; 13(1):1. PubMed ID: 30616626
[TBL] [Abstract][Full Text] [Related]
4. TALKIEN: crossTALK IntEraction Network. A web-based tool for deciphering molecular communication through ligand-receptor interactions.
Moratalla-Navarro F; Moreno V; Sanz-Pamplona R
Mol Omics; 2023 Oct; 19(9):688-696. PubMed ID: 37403821
[TBL] [Abstract][Full Text] [Related]
5. Modeling in systems biology: Causal understanding before prediction?
Barsi S; Szalai B
Patterns (N Y); 2021 Jun; 2(6):100280. PubMed ID: 34179849
[TBL] [Abstract][Full Text] [Related]
6. In-silico and in-vitro evidence suggest LINC01405 as a sponge for miR-29b and miR-497-5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma.
Norouzi R; Mohamadzade Z; Norouzi R; Norouzi R; Esmaeili R; Soltani BM
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1972. PubMed ID: 38225865
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.
Li P; Ma X; Huang D; Gu X
Int J Immunopathol Pharmacol; 2023; 37():3946320231218179. PubMed ID: 38054921
[No Abstract] [Full Text] [Related]
8. Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.
Beljkas M; Ilic A; Cebzan A; Radovic B; Djokovic N; Ruzic D; Nikolic K; Oljacic S
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004560
[TBL] [Abstract][Full Text] [Related]
9. Role of ZNF143 and Its Association with Gene Expression Patterns, Noncoding Mutations, and the Immune System in Human Breast Cancer.
Saddeek S; Almassabi R; Mobashir M
Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675976
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
11. Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer.
Khouja HI; Ashankyty IM; Bajrai LH; Kumar PKP; Kamal MA; Firoz A; Mobashir M
Sci Rep; 2022 May; 12(1):7240. PubMed ID: 35508649
[TBL] [Abstract][Full Text] [Related]
12. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
[TBL] [Abstract][Full Text] [Related]
13. Proteogenomic convergence for understanding cancer pathways and networks.
Boja ES; Rodriguez H
Clin Proteomics; 2014; 11(1):22. PubMed ID: 24994965
[TBL] [Abstract][Full Text] [Related]
14. An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation.
Mobashir M; Turunen SP; Izhari MA; Ashankyty IM; Helleday T; Lehti K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552885
[TBL] [Abstract][Full Text] [Related]
15. Network analysis of an in vitro model of androgen-resistance in prostate cancer.
Detchokul S; Elangovan A; Crampin EJ; Davis MJ; Frauman AG
BMC Cancer; 2015 Nov; 15():883. PubMed ID: 26553226
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
